34° Sunny

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition
STOCKING STUFFER CONTEST

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,038.81 -23.38 (-2.20%)

Streaming Delayed Price Updated: 1:15 PM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

99 100 Next >

Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies ↗

October 23, 2025

Viking Therapeutics stock popped Thursday on the lightening pace it's enrolling patients in a pair of obesity treatment tests.

Via Investor's Business Daily

Eccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug, AstraZeneca Partnership ↗

October 23, 2025

Via Benzinga

Topics Initial Public Offering

4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA)

October 23, 2025

Via AB Newswire

Weight Loss Drugs Are Quietly Exploding Employer Health Insurance Costs: 'There Is A Quiet Alarm Bell Going Off' ↗

October 23, 2025

Employer-sponsored health insurance costs rise for third year, with average family premiums at $27,000 in 2025. Drug costs and GLP-1s drive spending.

Via Benzinga

Eli Lilly (LLY): 3 Reasons We Love This Stock

October 23, 2025

Since April 2025, Eli Lilly has been in a holding pattern, posting a small loss of 2.2% while floating around $811. The stock also fell short of the S&P 500’s 24.7% gain during that period.

Via StockStory

Topics Stocks Supply Chain

AI Revolutionizes Drug Discovery and Personalized Medicine: A New Era of Healthcare

October 22, 2025

The pharmaceutical and biotechnology industries are undergoing a profound transformation, driven by an urgent need for more efficient drug discovery and development processes and the paradigm shift...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence

Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence

October 22, 2025

San Francisco, CA – October 22, 2025 – Nurix Therapeutics (NASDAQ: NRIX) has captured significant market attention, with its stock experiencing a notable surge following the announcement of the...

Via MarketMinute

Novo Nordisk Shares Tumble Amid Sweeping Board Overhaul

October 22, 2025

Copenhagen, Denmark – October 22, 2025 – Novo Nordisk (NYSE: NVO) shares experienced a notable decline this week following the announcement of a comprehensive board overhaul, a decisive move...

Via MarketMinute

Topics Economy Government Intellectual Property

Big Money Exits: Iconic Pharma Stock Sold by High-Profile Asset Manager ↗

October 22, 2025

Big Money Exits: Iconic Pharma Stock Sold by High-Profile Asset Manager

Via The Motley Fool

3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report ↗

October 22, 2025

The rapid growth rates of recent years aren't guaranteed to continue.

Via The Motley Fool

Topics Intellectual Property

Got 1K to Invest? These 3 Stocks Are Still Attractive Buys ↗

October 21, 2025

Looking for high-upside stocks in 2025? AMD, UBER, and LLY each offer over 30% EPS growth potential and analyst-backed price targets with double-digit gains.

Via MarketBeat

Topics Artificial Intelligence

These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall ↗

October 21, 2025

Don't try to catch a falling surgical knife.

Via The Motley Fool

Topics Government

Did Eli Lilly Just Say "Checkmate" to Novo Nordisk? ↗

October 21, 2025

The tides continue to change in Eli Lilly's favor in the GLP-1 space.

Via The Motley Fool

3 Overrated Stocks That Fall Short

October 21, 2025

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Via StockStory

Big Pharma Just Put Peptides Back on the Map – Which Players Are Still Under the Radar?

October 20, 2025

Via AB Newswire

Here's How Much $100 Invested In Eli Lilly 20 Years Ago Would Be Worth Today ↗

October 20, 2025

Via Benzinga

Jim Cramer's Crystal Ball: Unpacking the Market's Top 10 Drivers for a Pivotal Monday

October 20, 2025

As the financial markets gear up for the week commencing Monday, October 20, 2025, investors are keenly attuned to the insights of CNBC's Jim Cramer, a vocal and influential voice in the stock market....

Via MarketMinute

Topics Artificial Intelligence Economy World Trade

Top 1% Celcuity Shoots To Record High On Roche-Rivaling Breast Cancer Results ↗

October 20, 2025

The company said its breast cancer treatment delayed progression for a median of 19.7 months in some patients.

Via Investor's Business Daily

Topics Government

These 3 Obesity Drug Stocks Are Set to Soar This Fall and Beyond ↗

October 20, 2025

These companies are jockeying for position in a potential $150 billion market opportunity.

Via The Motley Fool

3 Hyped Up Stocks We Think Twice About

October 20, 2025

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Via StockStory

J.L. Bainbridge Buys $45 Million in Eli Lilly Stock Despite Price-Pressure Fears ↗

October 19, 2025

Via The Motley Fool

Topics Regulatory Compliance

Investment Advisor Goes All-In on Big Pharma Stock to the Tune of $1.07 Billion, According to Recent Filing ↗

October 19, 2025

Via The Motley Fool

Topics Regulatory Compliance

Large Wealth Advisor Trims Exposure to Red-Hot Digital Advertising Stock ↗

October 19, 2025

Via The Motley Fool

Topics Regulatory Compliance

Got $5,000? 2 Stocks to Buy Now and Hold for the Long Term ↗

October 19, 2025

These two high-quality stocks can deliver impressive returns in the long run.

Via The Motley Fool

Topics Artificial Intelligence

'No Place Is Risk-Free Until The World Is Polio-Free:' Bill Gates Urges Global Action To Close Deadly Immunity Gaps ↗

October 19, 2025

Polio cases drop 99.9%, but funding shortfall could undo progress. Last mile hardest as virus exploits immunity gaps.

Via Benzinga

Benzinga Bulls And Bears: Stellantis, Papa John's, Oklo — And Trade Tensions Shake Chip Stocks ↗

October 18, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

Topics World Trade

Had You Invested $10,000 in the Vanguard S&P 500 Growth ETF 10 Years Ago, Here's How Much You'd Have Today ↗

October 18, 2025

The Vanguard S&P 500 Growth ETF typically outperforms the S&P 500 over the long term.

Via The Motley Fool

Topics Artificial Intelligence ETFs Economy

Trump's Weight-Loss Drug Push May Put These ETFs On A Diet ↗

October 17, 2025

Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.

Via Benzinga

Topics ETFs Government

Uncover the latest developments among S&P500 stocks in today's session. ↗

October 17, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

Via Chartmill

Trump-Induced Volatility Aside, Novo Trades Cheap While Patents Protect Its Profits Until 2032 ↗

October 17, 2025

Novo Nordisk offers cheap stock with strong moat and long-term growth tailwinds. Trump's drug price cut suggestion caused short-term volatility but...

Via Benzinga

Topics Government Intellectual Property

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Eli Lilly (NY:LLY)

All News about Eli Lilly

Sections

Services